BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15537049)

  • 1. Clinical trials in neurological disorders using AAV vectors: promises and challenges.
    Mandel RJ; Burger C
    Curr Opin Mol Ther; 2004 Oct; 6(5):482-90. PubMed ID: 15537049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders.
    Mandel RJ; Manfredsson FP; Foust KD; Rising A; Reimsnider S; Nash K; Burger C
    Mol Ther; 2006 Mar; 13(3):463-83. PubMed ID: 16412695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of AAV vectors in the treatment of metabolic disease.
    Alexander IE; Cunningham SC; Logan GJ; Christodoulou J
    Gene Ther; 2008 Jun; 15(11):831-9. PubMed ID: 18401432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease.
    Mandel RJ
    Curr Opin Mol Ther; 2010 Apr; 12(2):240-7. PubMed ID: 20373268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of viral vectors for neurological gene therapies.
    Maguire-Zeiss KA; Federoff HJ
    Curr Opin Mol Ther; 2004 Oct; 6(5):473-81. PubMed ID: 15537048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.
    Le Bec C; Douar AM
    Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated gene therapy for retinal disorders: from mouse to man.
    Buch PK; Bainbridge JW; Ali RR
    Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of treating neurological diseases by gene therapy.
    Lundstrom K
    Curr Opin Investig Drugs; 2007 Jan; 8(1):34-40. PubMed ID: 17263183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of HSV vectors to modify the nervous system.
    Glorioso JC; Fink DJ
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):289-95. PubMed ID: 11926135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.
    Grieger JC; Samulski RJ
    Adv Biochem Eng Biotechnol; 2005; 99():119-45. PubMed ID: 16568890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manufacturing and characterizing AAV-based vectors for use in clinical studies.
    Wright JF
    Gene Ther; 2008 Jun; 15(11):840-8. PubMed ID: 18418418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current issues in adeno-associated viral vector production.
    Merten OW; Gény-Fiamma C; Douar AM
    Gene Ther; 2005 Oct; 12 Suppl 1():S51-61. PubMed ID: 16231056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of gene therapy for neurological disorders.
    Manfredsson FP; Mandel RJ
    Discov Med; 2010 Mar; 9(46):204-11. PubMed ID: 20350486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AAV vectors for hemophilia B gene therapy.
    Chao H; Walsh CE
    Mt Sinai J Med; 2004 Oct; 71(5):305-13. PubMed ID: 15543431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects.
    Hasbrouck NC; High KA
    Gene Ther; 2008 Jun; 15(11):870-5. PubMed ID: 18432276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of adeno-associated viral vectors.
    Grieger JC; Choi VW; Samulski RJ
    Nat Protoc; 2006; 1(3):1412-28. PubMed ID: 17406430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.